Skip to Main Content

INFORMATION FOR

Jeanne Hendrickson, MD

Professor Adjunct

Contact Information

Jeanne Hendrickson, MD

Mailing Address

  • Laboratory Medicine

    330 Cedar Street, PO Box 208035

    New Haven, CT 06520-8035

    United States

Research Summary

Jeanne Hendrickson studies complications of transfusion therapy, including the development of immune responses to antigens expressed on transfused blood products. Millions of blood products are transfused annually, and immune responses to transfused red blood cells or platelets or white blood cells may complicate future transfusions, pregnancies, or organ transplantation. Factors influencing alloimmunization, including those on the donor and recipient sides of the equation, are studied. Environmental and genetic variables that impact the intersections of innate and adaptive immunity are also studied. Some studies involve reductionist models with expression of authentic human blood group antigens, whereas others are more translational/patient focused.

Extensive Research Description

Please pubmed search Hendrickson JE to see the range of topics the Hendrickson lab is interested in. In general, the lab is interested in investigating clinically relevant issues in transfusion medicine using basic science models and translational research tools.

Cellular therapy; Red blood cell alloimmunization

Coauthors

Research Interests

Anemia, Sickle Cell; Blood Transfusion; Hematology; Immune Tolerance; Plasmapheresis; Pregnancy Complications, Hematologic; Immunity, Humoral; Transfusion Medicine

Selected Publications

  • SRSF2 or TET2 Mutations in Patients with MDS Predict Increased Red Blood Cell AlloimmunizationGuarente J, Hendrickson J, Li F, Parziale S, Tormey C, Siddon A. SRSF2 or TET2 Mutations in Patients with MDS Predict Increased Red Blood Cell Alloimmunization Blood 2022, 140: 5706-5707. DOI: 10.1182/blood-2022-169888.
  • A US-Wide Red Blood Cell Alloantibody Exchange Can Decrease Mortality and Produce Cost Savings in the Care of Alloimmunized Patients with Sickle Cell DiseaseGoshua G, Hauser R, Tormey C, Pandya A, Hendrickson J. A US-Wide Red Blood Cell Alloantibody Exchange Can Decrease Mortality and Produce Cost Savings in the Care of Alloimmunized Patients with Sickle Cell Disease Blood 2022, 140: 2147-2148. DOI: 10.1182/blood-2022-169099.
  • Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated ImmunosuppressionJajosky R, Allen J, Zerra P, Maier C, Chonat S, Luckey C, Roback J, Fasano R, Josephson C, Manis J, Chai L, Hendrickson J, Hudson K, Arthur C, Stowell S. Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression Blood 2022, 140: 73-74. DOI: 10.1182/blood-2022-170081.
  • Transfusion in infants and childrenHendrickson J, Josephson C. Transfusion in infants and children 2022, 381-391. DOI: 10.1002/9781119719809.ch34.
  • Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System ExperienceBrowning S, Gormally M, Briggs N, Li M, Zakko A, Laurent-Rolle M, Ladines-Lim J, Morrison A, Kandel P, Khan M, McLeod G, Buller G, Owusu K, Treggiari M, Hendrickson J, Tormey C, Desruisseaux M. Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience Blood 2020, 136: 39-40. PMCID: PMC8330251, DOI: 10.1182/blood-2020-137352.
  • Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic PurpuraGoshua G, Sinha P, Hendrickson J, Tormey C, Bendapudi P, Lee A. Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura Blood 2020, 136: 18-19. DOI: 10.1182/blood-2020-138515.
  • Optimization of Plerixafor Utilization Based on Peripheral Blood CD34+ Count for Autologous Peripheral Blood Stem-Cell CollectionGupta G, Perreault S, Seropian S, Tormey C, Hendrickson J. Optimization of Plerixafor Utilization Based on Peripheral Blood CD34+ Count for Autologous Peripheral Blood Stem-Cell Collection Blood 2020, 136: 41-41. DOI: 10.1182/blood-2020-140171.
  • Type I Interferon Gene Signature in Peripheral Blood Mononuclear Cells of Sickle Cell Disease Patients and a Connection to RBC AlloimmunizationMadany E, Lee J, Hendrickson J, Gibb D. Type I Interferon Gene Signature in Peripheral Blood Mononuclear Cells of Sickle Cell Disease Patients and a Connection to RBC Alloimmunization Blood 2020, 136: 26-27. DOI: 10.1182/blood-2020-142935.
  • Assessment of Factor V Activity in Apheresis Platelet Units: Implications for Management of FV DeficiencyGupta G, Hendrickson J, Bahel P, Siddon A, Rinder H, Tormey C. Assessment of Factor V Activity in Apheresis Platelet Units: Implications for Management of FV Deficiency American Journal Of Clinical Pathology 2020, 154: s6-s7. DOI: 10.1093/ajcp/aqaa137.011.
  • Co-Culture of Acinetobacter calcoaceticus-baumannii complex and Staphylococcus saprophyticus Supports Simple Point Contamination Model in Recent Cases of Transfusion-Related SepsisKerantzas C, Merwede J, Snyder E, Hendrickson J, Tormey C, Kazmierczak B, Peaper D. Co-Culture of Acinetobacter calcoaceticus-baumannii complex and Staphylococcus saprophyticus Supports Simple Point Contamination Model in Recent Cases of Transfusion-Related Sepsis American Journal Of Clinical Pathology 2020, 154: s14-s14. DOI: 10.1093/ajcp/aqaa137.025.
  • Passive Transfer Of Allo-Antibodies Following Rhig Administration Given For Rh-Mismatched Platelets ProphylaxisSostin N, Hendrickson J, Balbuena-Merle R, Tormey C. Passive Transfer Of Allo-Antibodies Following Rhig Administration Given For Rh-Mismatched Platelets Prophylaxis American Journal Of Clinical Pathology 2020, 154: s158-s159. DOI: 10.1093/ajcp/aqaa161.346.
  • The Presence and Persistence of Pregnancy-Associated Red Blood Cell Alloantibodies in Blood DonorsBalbuena-Merle R, Hauser R, Karafin M, Tan S, Spencer B, Roubinian N, Wu Y, Triulzi D, Kleinman S, Gottschall J, Tormey C, Hendrickson J. The Presence and Persistence of Pregnancy-Associated Red Blood Cell Alloantibodies in Blood Donors Blood 2019, 134: 2452-2452. DOI: 10.1182/blood-2019-121388.
  • Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain TypesCurtis S, Forray A, Hendrickson J, Roberts J. Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain Types Blood 2019, 134: 1028-1028. DOI: 10.1182/blood-2019-129106.
  • Increased Expression of Type 1 Interferon Stimulated Genes in Sickle Cell Disease and a Potential Association with RBC AlloimmunizationMadany E, El Kadi N, Pandya S, Hendrickson J, Gibb D. Increased Expression of Type 1 Interferon Stimulated Genes in Sickle Cell Disease and a Potential Association with RBC Alloimmunization Blood 2019, 134: 716-716. DOI: 10.1182/blood-2019-124899.
  • Recipient factors influencing red blood cell alloimmunizationHendrickson J. Recipient factors influencing red blood cell alloimmunization ISBT Science Series 2019, 15: 194-200. DOI: 10.1111/voxs.12485.
  • Restrictive Transfusions in the Era of Pathogen-Inactivated Platelets: A Single Center ExperienceShallis R, Gleeson S, Chokr N, Fangyong L, Wei W, Azar M, Schulz W, Summers D, Hendrickson J, Foss F, Isufi I, Kim T, Pillai M, Snyder E, Seropian S, Gowda L. Restrictive Transfusions in the Era of Pathogen-Inactivated Platelets: A Single Center Experience Transplantation And Cellular Therapy 2019, 25: s365. DOI: 10.1016/j.bbmt.2018.12.591.
  • Chapter 57 Platelet Transfusion Refractory PatientsTormey C, Hendrickson J. Chapter 57 Platelet Transfusion Refractory Patients 2019, 361-364. DOI: 10.1016/b978-0-12-813726-0.00057-x.
  • Chapter 49 Neonatal and Pediatric Transfusion MedicineZerra P, Hendrickson J, Josephson C. Chapter 49 Neonatal and Pediatric Transfusion Medicine 2019, 295-299. DOI: 10.1016/b978-0-12-813726-0.00049-0.
  • Chapter 53 Transfusion Management of Patients Undergoing Hematopoietic Stem Cell and Solid Organ TransplantationRutter S, Hendrickson J. Chapter 53 Transfusion Management of Patients Undergoing Hematopoietic Stem Cell and Solid Organ Transplantation 2019, 337-341. DOI: 10.1016/b978-0-12-813726-0.00053-2.
  • Chapter 56 Management of Patients Who Refuse Blood TransfusionBahar B, Hendrickson J. Chapter 56 Management of Patients Who Refuse Blood Transfusion 2019, 357-360. DOI: 10.1016/b978-0-12-813726-0.00056-8.
  • Chapter 65 Transfusion-Associated Circulatory OverloadGokhale A, Hendrickson J. Chapter 65 Transfusion-Associated Circulatory Overload 2019, 401-404. DOI: 10.1016/b978-0-12-813726-0.00065-9.
  • Chapter 66 Transfusion-Related Acute Lung InjuryGokhale A, Hendrickson J. Chapter 66 Transfusion-Related Acute Lung Injury 2019, 405-408. DOI: 10.1016/b978-0-12-813726-0.00066-0.
  • Elevated Levels of CD64 MFI on Monocyte Subsets Are Associated with a History of Stroke in Sickle Cell DiseaseCurtis S, Balbuena-Merle R, Devine L, Zelterman D, Roberts J, Dearborn-Tomazos J, Sansing L, Hendrickson J. Elevated Levels of CD64 MFI on Monocyte Subsets Are Associated with a History of Stroke in Sickle Cell Disease Blood 2018, 132: 1093-1093. DOI: 10.1182/blood-2018-99-117504.
  • Cost Effectiveness of Rituximab As Adjunctive Therapy in Reducing Apheresis Procedures and Hospital Length of Stay in Relapsed Thrombotic Thrombocytopenic PurpuraGoshua G, Gokhale A, Hendrickson J, Tormey C, Lee A. Cost Effectiveness of Rituximab As Adjunctive Therapy in Reducing Apheresis Procedures and Hospital Length of Stay in Relapsed Thrombotic Thrombocytopenic Purpura Blood 2018, 132: 3814-3814. DOI: 10.1182/blood-2018-99-113621.
  • Influenza Infection Induces RBC Alloimmunization By a Type 1 Interferon Dependent MechanismGibb D, Liu D, Liu J, Santhanakrishnan M, Eisenbarth S, Hendrickson J. Influenza Infection Induces RBC Alloimmunization By a Type 1 Interferon Dependent Mechanism Blood 2018, 132: 743-743. DOI: 10.1182/blood-2018-99-110884.
  • HLA Class I Alloimmunization and Platelet Transfusion Support in HLA-Identical Bone Marrow Transplant for Sickle Cell Disease: A Sickle Transplant Alliance for Research StudyNickel R, Horan J, Abraham A, Qayed M, Haight A, Luban N, Hendrickson J. HLA Class I Alloimmunization and Platelet Transfusion Support in HLA-Identical Bone Marrow Transplant for Sickle Cell Disease: A Sickle Transplant Alliance for Research Study Blood 2018, 132: 3816-3816. DOI: 10.1182/blood-2018-99-114116.
  • 6 A Novel Association Between High Red Blood Cell Alloimmunization Rates and Hereditary Hemorrhagic Telangiectasia (HHT)Zheng Y, Pollak J, Henderson K, Hendrickson J, Tormey C. 6 A Novel Association Between High Red Blood Cell Alloimmunization Rates and Hereditary Hemorrhagic Telangiectasia (HHT) American Journal Of Clinical Pathology 2018, 149: s166-s166. DOI: 10.1093/ajcp/aqx149.375.
  • 1 Type I Interferon Is Necessary and Sufficient for Alloimmunization to Transfused KEL-Expressing RBCs in MiceGibb D, Liu J, Natarajan P, Santhanakrishnan M, Madrid D, Eisenbarth S, Zimring J, Iwasaki A, Hendrickson J. 1 Type I Interferon Is Necessary and Sufficient for Alloimmunization to Transfused KEL-Expressing RBCs in Mice American Journal Of Clinical Pathology 2018, 149: s163-s163. DOI: 10.1093/ajcp/aqx149.370.
  • 3 The Importance of CD4 Cells and CD40/CD40 Ligand Interactions in Humoral Immune Responses to Transfused KEL RBCs in MiceMadrid D, Gibb D, Natarajan P, Santhanakrishnan M, Liu J, Hendrickson J. 3 The Importance of CD4 Cells and CD40/CD40 Ligand Interactions in Humoral Immune Responses to Transfused KEL RBCs in Mice American Journal Of Clinical Pathology 2018, 149: s164-s164. DOI: 10.1093/ajcp/aqx149.372.
  • 9 Examining the Correlation Between Microbial Pathogen Sequence Structure and Blood Group Antigen ImmunogenicityBahar B, Baine I, Hendrickson J, Tormey C. 9 Examining the Correlation Between Microbial Pathogen Sequence Structure and Blood Group Antigen Immunogenicity American Journal Of Clinical Pathology 2018, 149: s167-s168. DOI: 10.1093/ajcp/aqx149.378.
  • Chapter 21 Data Interpretation in Laboratory MedicineTormey C, Gehrie E, Pham H, Bucy R, Lorenz R, Zheng X, Hendrickson J. Chapter 21 Data Interpretation in Laboratory Medicine 2018, 489-510. DOI: 10.1016/b978-0-12-803999-1.00021-3.
  • Chapter 4 Common Significant Non-ABO Antibodies and Blood Group Antigen AlloimmunizationBaine I, Hendrickson J, Tormey C. Chapter 4 Common Significant Non-ABO Antibodies and Blood Group Antigen Alloimmunization 2018, 25-39. DOI: 10.1016/b978-0-323-54458-0.00004-0.
  • Red blood cell alloimmunisation: induction of immunity and potential mitigation strategiesHendrickson J. Red blood cell alloimmunisation: induction of immunity and potential mitigation strategies ISBT Science Series 2017, 13: 105-111. DOI: 10.1111/voxs.12360.
  • Transfusion Support of the Patient with Sickle Cell Disease Undergoing TransplantationHendrickson J, Fasano R. Transfusion Support of the Patient with Sickle Cell Disease Undergoing Transplantation 2017, 111-136. DOI: 10.1007/978-3-319-62328-3_5.
  • Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic MalignanciesAsare M, Hendrickson J, Tormey C. Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies Blood 2016, 128: 1463-1463. DOI: 10.1182/blood.v128.22.1463.1463.
  • Type 1 Interferon Regulates Inflammation Associated RBC Alloimmunization By Promoting Monocyte-Derived Dendritic Cell Erythrophagocytosis in MiceGibb D, Natarajan P, Liu J, Santhanakrishnan M, Iwasaki A, Hendrickson J. Type 1 Interferon Regulates Inflammation Associated RBC Alloimmunization By Promoting Monocyte-Derived Dendritic Cell Erythrophagocytosis in Mice Blood 2016, 128: 19-19. DOI: 10.1182/blood.v128.22.19.19.
  • Transfusion MedicineHendrickson J, Tormey C. Transfusion Medicine Hematology/Oncology Clinics Of North America 2016, 30: i. DOI: 10.1016/s0889-8588(16)30041-7.
  • Platelet and plasma transfusions for infants and childrenHendrickson J, Josephson C. Platelet and plasma transfusions for infants and children 2016, 542-548. DOI: 10.1002/9781119013020.ch47.
  • North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute LeukemiaPine A, Lee E, Sekeres M, Steensma D, Prebet T, DeZern A, Komrokji R, Litzow M, Luger S, Stone R, Erba H, Garcia-Manero G, Lee A, Podoltsev N, Barbarotta L, Hendrickson J, Gore S, Zeidan A. North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia Blood 2015, 126: 1138-1138. DOI: 10.1182/blood.v126.23.1138.1138.
  • A Novel Network Analysis Tool to Identify Relationships Between Disease States and Risk for RBC AlloimmunizationCelli R, Schulz W, Hendrickson J, Tormey C. A Novel Network Analysis Tool to Identify Relationships Between Disease States and Risk for RBC Alloimmunization Blood 2015, 126: 2349-2349. DOI: 10.1182/blood.v126.23.2349.2349.
  • DOCK8-Deficient Mice Reveal a Crucial Role for Dendritic Cell Activity in the Initiation of the Allogeneic Response to Transfused Red Blood CellsEisenbarth S, Hendrickson J, Calabro S, Gallman A. DOCK8-Deficient Mice Reveal a Crucial Role for Dendritic Cell Activity in the Initiation of the Allogeneic Response to Transfused Red Blood Cells Blood 2015, 126: 658-658. DOI: 10.1182/blood.v126.23.658.658.
  • Anti-RhD Mediates Loss of RhD Antigen Following Anti-RhD InfusionSullivan H, Arthur C, Patel S, Hendrickson J, Lazarus A, Stowell S. Anti-RhD Mediates Loss of RhD Antigen Following Anti-RhD Infusion Blood 2015, 126: 3570-3570. DOI: 10.1182/blood.v126.23.3570.3570.
  • Antigen Density Impacts RBC Survival and Antigen Modulation Following Incompatible RBC TransfusionYoo J, Arthur C, Zerra P, Girard-Pierce K, Hendrickson J, Stowell S. Antigen Density Impacts RBC Survival and Antigen Modulation Following Incompatible RBC Transfusion Blood 2015, 126: 2350-2350. DOI: 10.1182/blood.v126.23.2350.2350.
  • INNATE AND ADAPTIVE IMMUNE RESPONSES TO TRANSFUSED ALLOANTIGENSZimring J, Hudson K, Hendrickson J. INNATE AND ADAPTIVE IMMUNE RESPONSES TO TRANSFUSED ALLOANTIGENS Pathology 2015, 47: s41. DOI: 10.1097/01.pat.0000461433.20240.46.
  • INNATE AND ADAPTIVE IMMUNE RESPONSES TO TRANSFUSED ALLOANTIGENSZimring J, Hudson K, Hendrickson J. INNATE AND ADAPTIVE IMMUNE RESPONSES TO TRANSFUSED ALLOANTIGENS Pathology 2015, 47: s34. DOI: 10.1097/01.pat.0000461421.80336.37.
  • Chronic Inflammatory Autoimmune Disorders Are a Risk Factor for Blood Group Alloimmunization in Transfused PatientsRyder A, Hendrickson J, Tormey C. Chronic Inflammatory Autoimmune Disorders Are a Risk Factor for Blood Group Alloimmunization in Transfused Patients Blood 2014, 124: 4294-4294. DOI: 10.1182/blood.v124.21.4294.4294.
  • Polyclonal Anti-Kel (KELGAM) Prevents Alloimmunization to Transfused Kel RBCs in a Murine ModelStowell S, Arthur C, Girard-Pierce K, Sullivan H, Santhanakrishnan M, Natarajan P, Tormey C, Zimring J, Hendrickson J. Polyclonal Anti-Kel (KELGAM) Prevents Alloimmunization to Transfused Kel RBCs in a Murine Model Blood 2014, 124: 758-758. DOI: 10.1182/blood.v124.21.758.758.
  • NLRP10-Deficient Mice Reveal a Crucial Role for Dendritic Cell Activity in the Initiation of the Allogeneic Response to Transfused Red Blood CellsEisenbarth S, Hendrickson J, Calabro S, Gallman A. NLRP10-Deficient Mice Reveal a Crucial Role for Dendritic Cell Activity in the Initiation of the Allogeneic Response to Transfused Red Blood Cells Blood 2014, 124: 4113-4113. DOI: 10.1182/blood.v124.21.4113.4113.
  • Reticuloendothelial Saturation Dictates the Development of RBC Resistance to Antibody-Mediated Clearance Following Incompatible TransfusionArthur C, Mener A, Patel S, Rodrigues L, Xue C, Nickel R, Zimring J, Hendrickson J, Stowell S. Reticuloendothelial Saturation Dictates the Development of RBC Resistance to Antibody-Mediated Clearance Following Incompatible Transfusion Blood 2014, 124: 1559-1559. DOI: 10.1182/blood.v124.21.1559.1559.
  • CD8+ T Cells Mediate Antibody-Independent Platelet Clearance Following TransfusionPatel S, Arthur C, Rodrigues L, Xue C, Zimring J, Hendrickson J, Stowell S. CD8+ T Cells Mediate Antibody-Independent Platelet Clearance Following Transfusion Blood 2014, 124: 596-596. DOI: 10.1182/blood.v124.21.596.596.
  • Coagulopathy Predicts Mortality in Pediatric Patients with Traumatic Brain InjuryDoshi B, Meeks S, Hendrickson J, Reisner A, Leong T, Winkler A, Meyer E. Coagulopathy Predicts Mortality in Pediatric Patients with Traumatic Brain Injury Blood 2014, 124: 2891-2891. DOI: 10.1182/blood.v124.21.2891.2891.
  • The RBC as a Target of DamageHendrickson J, Tormey C. The RBC as a Target of Damage 2014, 3068-3080. DOI: 10.1016/b978-0-12-386456-7.06203-1.
  • KEL RBC Transfusion Induces IgG Anti-KEL Antibodies Independent Of CD4 T CellsStowell S, Girard-Pierce K, Arthur C, Smith N, Zimring J, Hendrickson J. KEL RBC Transfusion Induces IgG Anti-KEL Antibodies Independent Of CD4 T Cells Blood 2013, 122: 41-41. DOI: 10.1182/blood.v122.21.41.41.
  • Transfusion Of RBCs With Low-Density KEL Induces Tolerance To The KEL AntigenStowell S, Arthur C, Smith N, Girard-Pierce K, Zimring J, Hendrickson J. Transfusion Of RBCs With Low-Density KEL Induces Tolerance To The KEL Antigen Blood 2013, 122: 1160-1160. DOI: 10.1182/blood.v122.21.1160.1160.
  • Alloimmunization To HLA Class I Antigens But Not H-Y Antigens Is Associated With Transfusion In Children With Sickle Cell DiseaseNickel R, Hendrickson J, Kean L, McPherson Yee M, Bray R, Gebel H, Miklos D, Horan J. Alloimmunization To HLA Class I Antigens But Not H-Y Antigens Is Associated With Transfusion In Children With Sickle Cell Disease Blood 2013, 122: 39-39. DOI: 10.1182/blood.v122.21.39.39.
  • Storage-Induced Clearance Of RBCs Following Transfusion Occurs Independent Of RBC AgeArthur C, Smith N, Zimring J, Hendrickson J, Stowell S. Storage-Induced Clearance Of RBCs Following Transfusion Occurs Independent Of RBC Age Blood 2013, 122: 792-792. DOI: 10.1182/blood.v122.21.792.792.
  • Red Blood Cell Alloimmunization and Hemolytic Disease of the Fetus and Newborn: New Approaches Using Animal ModelsHendrickson J. Red Blood Cell Alloimmunization and Hemolytic Disease of the Fetus and Newborn: New Approaches Using Animal Models Blood 2013, 122: sci-49-sci-49. DOI: 10.1182/blood.v122.21.sci-49.sci-49.
  • Alterations In Specific Immune Cell Subsets In Children With Sickle Cell DiseaseNickel R, Hendrickson J, Horan J, Garrett A, Robertson J, Osunkwo I, Kean L. Alterations In Specific Immune Cell Subsets In Children With Sickle Cell Disease Blood 2013, 122: 2208-2208. DOI: 10.1182/blood.v122.21.2208.2208.
  • Chapter 54 Management of Patients Who Refuse Blood TransfusionHendrickson J. Chapter 54 Management of Patients Who Refuse Blood Transfusion 2013, 357-360. DOI: 10.1016/b978-0-12-397164-7.00054-9.
  • Chapter 51 Transfusion of Patients Undergoing Hematopoietic Stem Cell and Solid Organ TransplantationHendrickson J. Chapter 51 Transfusion of Patients Undergoing Hematopoietic Stem Cell and Solid Organ Transplantation 2013, 337-342. DOI: 10.1016/b978-0-12-397164-7.00051-3.
  • Chapter 64 Transfusion-Related Acute Lung InjuryHendrickson J, Hillyer C. Chapter 64 Transfusion-Related Acute Lung Injury 2013, 417-420. DOI: 10.1016/b978-0-12-397164-7.00064-1.
  • Chapter 63 Transfusion-Associated Circulatory OverloadHendrickson J, Hillyer C. Chapter 63 Transfusion-Associated Circulatory Overload 2013, 413-415. DOI: 10.1016/b978-0-12-397164-7.00063-x.
  • Chapter 55 Platelet Transfusion Refractory PatientsHendrickson J. Chapter 55 Platelet Transfusion Refractory Patients 2013, 361-365. DOI: 10.1016/b978-0-12-397164-7.00055-0.
  • Chapter 47 Neonatal and Pediatric Transfusion MedicineHendrickson J, Josephson C. Chapter 47 Neonatal and Pediatric Transfusion Medicine 2013, 301-305. DOI: 10.1016/b978-0-12-397164-7.00047-1.
  • Development of a Murine Model of Weak Kel: Similarities to Weak Rh(D)Hendrickson J, Smith N, Girard-Pierce K, Tormey C, Henry K, Zimring J, Stowell S. Development of a Murine Model of Weak Kel: Similarities to Weak Rh(D) Blood 2012, 120: 842-842. DOI: 10.1182/blood.v120.21.842.842.
  • Marginal Zone B Cells Mediate Alloantibody Formation to a Clinically Significant Human RBC Antigen in a Murine ModelGirard-Pierce K, Stowell S, Smith N, Henry K, Zimring J, Hendrickson J. Marginal Zone B Cells Mediate Alloantibody Formation to a Clinically Significant Human RBC Antigen in a Murine Model Blood 2012, 120: 843-843. DOI: 10.1182/blood.v120.21.843.843.
  • A Genetic Basis for Donor Variation in Generation of Prostaglandins and Leukotrienes in Stored RBCs Using a Mouse ModelZimring J, Smith N, Stowell S, Francis R, Hod E, Hendrickson J, Dumont L, Roback J, Spitalnik S. A Genetic Basis for Donor Variation in Generation of Prostaglandins and Leukotrienes in Stored RBCs Using a Mouse Model Blood 2012, 120: 844-844. DOI: 10.1182/blood.v120.21.844.844.
  • Cellular Protection Against Antibodies Occurs Through a Complement-Independent PathwayStowell S, Liepkalns J, Hendrickson J, Pierce K, Smith N, Zimring J. Cellular Protection Against Antibodies Occurs Through a Complement-Independent Pathway Blood 2012, 120: 3290-3290. DOI: 10.1182/blood.v120.21.3290.3290.
  • Coagulation, Bleeding, and Blood TransfusionMiller B, Hendrickson J. Coagulation, Bleeding, and Blood Transfusion 2011, 224-254. DOI: 10.1002/9781444345186.ch11.
  • Central T Cell Tolerance and Peripheral B Cell Tolerance for An RBC Autoantigen Are Incomplete in Healthy Mice; Implications for AIHA PathogenesisHudson K, Hendrickson J, Cadwell C, Iwakoshi N, Zimring J. Central T Cell Tolerance and Peripheral B Cell Tolerance for An RBC Autoantigen Are Incomplete in Healthy Mice; Implications for AIHA Pathogenesis Blood 2011, 118: 693-693. DOI: 10.1182/blood.v118.21.693.693.
  • A Novel Murine Model of Pregnancy and Transfusion Induced Anti-Kell RBC AlloimmunizationSmith N, Henry K, Zimring J, Hendrickson J. A Novel Murine Model of Pregnancy and Transfusion Induced Anti-Kell RBC Alloimmunization Blood 2011, 118: 715-715. DOI: 10.1182/blood.v118.21.715.715.
  • Fresh Murine Red Blood Cells Abrogate the Enhanced Alloimmunogenicity of Stored Murine Red Blood CellsHendrickson J, Hod E, Spitalnik S, Zimring J. Fresh Murine Red Blood Cells Abrogate the Enhanced Alloimmunogenicity of Stored Murine Red Blood Cells Blood 2010, 116: 663-663. DOI: 10.1182/blood.v116.21.663.663.
  • Leukoreduction Decreases Alloimmunogenicity of Transfused Murine HOD RBCs.Hendrickson J, Hod E, Spitalnik S, Hillyer C, Zimring J. Leukoreduction Decreases Alloimmunogenicity of Transfused Murine HOD RBCs. Blood 2009, 114: 640-640. DOI: 10.1182/blood.v114.22.640.640.
  • Chapter 47 Transfusion of HIV-positive PatientsHendrickson J, Roback J. Chapter 47 Transfusion of HIV-positive Patients 2009, 275-278. DOI: 10.1016/b978-0-12-374432-6.00047-6.
  • Chapter 48 Management of Patients Who Refuse Blood TransfusionHendrickson J, Roback J. Chapter 48 Management of Patients Who Refuse Blood Transfusion 2009, 279-282. DOI: 10.1016/b978-0-12-374432-6.00048-8.
  • Chapter 49 Platelet Transfusion Refractory PatientsHendrickson J, Roback J. Chapter 49 Platelet Transfusion Refractory Patients 2009, 283-286. DOI: 10.1016/b978-0-12-374432-6.00049-x.
  • Chapter 42 Neonatal and Pediatric Transfusion MedicineHendrickson J, Josephson C. Chapter 42 Neonatal and Pediatric Transfusion Medicine 2009, 235-239. DOI: 10.1016/b978-0-12-374432-6.00042-7.
  • Chapter 57 Transfusion Associated Circulatory OverloadHendrickson J, Hillyer C. Chapter 57 Transfusion Associated Circulatory Overload 2009, 327-329. DOI: 10.1016/b978-0-12-374432-6.00057-9.
  • Chapter 46 Transfusion of Patients Undergoing HPC and Solid-organ TransplantationHendrickson J, Roback J. Chapter 46 Transfusion of Patients Undergoing HPC and Solid-organ Transplantation 2009, 269-274. DOI: 10.1016/b978-0-12-374432-6.00046-4.
  • Chapter 58 Transfusion Related Acute Lung InjuryHendrickson J, Hillyer C. Chapter 58 Transfusion Related Acute Lung Injury 2009, 331-334. DOI: 10.1016/b978-0-12-374432-6.00058-0.
  • A Novel Model of Autoimmunity to Self Red Blood Cell AntigensHendrickson J, Cadwell C, Hillyer C, Zimring J. A Novel Model of Autoimmunity to Self Red Blood Cell Antigens Blood 2008, 112: 3461-3461. DOI: 10.1182/blood.v112.11.3461.3461.
  • Berkeley Mice with Sickle Cell Disease Are Not More Immunizable to Transfused HOD Red Blood Cells Than Sickle Trait Control MiceHendricKson J, Archer D, Perry J, Hillyer C, Zimring J. Berkeley Mice with Sickle Cell Disease Are Not More Immunizable to Transfused HOD Red Blood Cells Than Sickle Trait Control Mice Blood 2008, 112: 292-292. DOI: 10.1182/blood.v112.11.292.292.
  • An Intact Spleen Is Required for Alloimmunization to Transfused Red Blood Cells Due to Intrasplenic Activation of CD4+ T Cells.Hendrickson J, Roback J, Hillyer C, Zimring J. An Intact Spleen Is Required for Alloimmunization to Transfused Red Blood Cells Due to Intrasplenic Activation of CD4+ T Cells. Blood 2007, 110: 453-453. DOI: 10.1182/blood.v110.11.453.453.
  • Recipient Inflammation That Increases Alloimmunization Also Enhances Consumption of Transfused RBCs by Dendritic Cells.Hendrickson J, Roback J, Hillyer C, Zimring J. Recipient Inflammation That Increases Alloimmunization Also Enhances Consumption of Transfused RBCs by Dendritic Cells. Blood 2006, 108: 23-23. DOI: 10.1182/blood.v108.11.23.23.
  • Lack of Alloantibody Response to Red Blood Cell Antigens in Juvenile Mice Following Transfusion: Non-Immunogenic or Tolerogenic Response?.Hendrickson J, Josephson C, Chadwick T, Zimring J. Lack of Alloantibody Response to Red Blood Cell Antigens in Juvenile Mice Following Transfusion: Non-Immunogenic or Tolerogenic Response?. Blood 2006, 108: 955-955. DOI: 10.1182/blood.v108.11.955.955.
  • Host Inflammation Increases Alloimmunization to Transfused Red Blood Cells.Hendrickson J, Chadwick T, Roback J, Hillyer C, Zimring J. Host Inflammation Increases Alloimmunization to Transfused Red Blood Cells. Blood 2005, 106: 1887-1887. DOI: 10.1182/blood.v106.11.1887.1887.